Victoria backs IDT Australia to make anti-cancer drugs

The Victorian government has announced backing for pharmaceutical manufacturer IDT Australia to boost production of live-saving cancer treatments. IDT Australia will build a new facility in Boronia, Melbourne to manufacture Antibody Drug Conjugates (ADCs) which have the specificity of monoclonal antibodies and deliver chemotherapy agents to cancer tumor sites. ADCs are set to replace almost…

State government awards support to IDT for nation’s first ADC factory

Pharmaceutical manufacturer IDT Australia has announced that it has been awarded a Victorian government grant to assist in the establishment of an Australian-first facility for oncology drugs. In an ASX statement on Monday, IDT said it has established relationships with Antibody-Drug-Conjugate (ADC) biotech companies, including a master services  agreement with Japanese pharmaceutical company Nagase &…

Best of the week — the five most popular stories among readers, April 15 – 19, 2024

What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) From soft plastics waste to structural building panels Australian composites manufacturer Sustainable Infrastructure Systems (SIS) has revealed innovative structural building panels made from glass fibre-reinforced polymer (GFRP) and discarded soft plastics. The lightweight, high-strength composite panels are…

IDT and Sanofi to manufacture mRNA vaccines under development

Drug development company IDT Australia and pharmaceutical business Sanofi have signed an agreement for the good manufacturing practice (cGMP) manufacture of Sanofi’s mRNA vaccines now under development. The partners will collaborate to advance mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables filling facilities in Melbourne (pictured) in volumes needed for clinical trials…

Manufacturing news briefs – stories you might have missed

IDT Australia raises $2 million from shareholders Melbourne pharmaceutical manufacturer IDT Australia has raised $2 million via an over-subscribed share purchase plan to existing shareholders. The raising followed the successful completion of a $5 million placement to professional and sophisticated investors. The total capital raised will be used to fund the company’s capital expenditure programme…

IDT’s strong quarter delivers growth

Pharmaceutical manufacturer IDT Australia is seeing a surge in sales as demand for medical cannabis products rises and companies seek out more capable contract development and manufacturing organisations (CDMO). The Melbourne company told investors that revenues increased for the fourth quarter, with 4QFY23 revenue up 200 percent on the previous corresponding period to $2.4 million.…

Manufacturing news briefs – stories you might have missed

Australian Space Industry Capability Database to be launched The Space Industry Association of Australia has announced the Australian Space Industry Capability Database will launch to all users from mid-July 2023. The database will provide interactive data visualisations that demonstrate the scale and capability of the Australian space sector, including capability data, workforce data and detailed…